Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
04:21pm, Tuesday, 29'th Nov 2022 MarketWatch
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic.
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
11:00am, Tuesday, 29'th Nov 2022 The Motley Fool
Pfizer's revenue growth is far from over.
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
05:36pm, Monday, 28'th Nov 2022 MarketWatch
Widespread protests across China over the government's zero-COVID policy dominated headlines on the pandemic on Monday.
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
05:30pm, Monday, 28'th Nov 2022 Zacks Investment Research
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
2 Biotech Stocks You Can Buy and Hold for the Next Decade
01:30pm, Monday, 28'th Nov 2022 The Motley Fool
These two companies are facing short-term issues that are likely to give way to long-term success.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Monday, 28'th Nov 2022
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Gl
China's zero COVID strategy 'doesn't make public health sense,' says Fauci
09:13am, Monday, 28'th Nov 2022 MarketWatch
President Joe Biden's chief medical adviser, Dr. Anthony Fauci, says China's COVID-19 strategy of lockdowns without a better vaccination strategy doesn't make
4 Pharmaceutical Companies Among 19 To Announce Annual Dividend Increases In December
05:00am, Monday, 28'th Nov 2022
Among the 19 companies that are expected to announce annual dividend increases in December are drugmakers Eli Lilly, Pfizer, Bristol Myers Squibb, and Amgen. Investors are also waiting for Merck's inc
Is Novavax Stock a Buy Now?
03:37pm, Saturday, 26'th Nov 2022 The Motley Fool
There's probably not much good news coming for this biotech in the near future.
Better Dividend Stock: AbbVie or Viatris?
01:15pm, Saturday, 26'th Nov 2022 The Motley Fool
These pharmaceutical companies are profitable and offer above-average dividends.
Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven
07:50pm, Friday, 25'th Nov 2022
Joe Rosenberg's relationship with Barron's goes back to 1963, when he wrote a bullish article on Trans World Airlines that resulted in a pop in the stock.
As COVID cases rise, China locks down despite criticism
02:30pm, Friday, 25'th Nov 2022 MarketWatch
The restrictions are at the heart of the unrest in China as the country grapples with a rising number of infections after years of quarantine policies
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
05:47pm, Thursday, 24'th Nov 2022 MarketWatch
Less than 11% of Americans have opted to get the bivalent COVID-19 booster shot ahead of another pandemic winter and holiday season.
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
03:15pm, Thursday, 24'th Nov 2022 The Motley Fool
This drugmaker is among the most dominant pharmaceutical companies in the world.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
02:10pm, Thursday, 24'th Nov 2022 Zacks Investment Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco
